Diligence memo · auto-generated · as of July 2, 2026
Pico-Tesla Magnetic Therapies, LLC.
Pico-Tesla Magnetic Therapies, LLC. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Pico-Tesla Magnetic Therapies, LLC. operates in Other Health Care, based in CLEARWATER.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Pico-Tesla Magnetic Therapies, LLC. has raised $49M in disclosed capital across 20 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.7M on 2010-02-12.
Most recent recorded round closed around 2010-02-12.
Filings read as a recurring offering program rather than a clean venture-stage ladder — interpret stage labels and step-ups with that in mind.
Valuation (modeled)modeled
Provath models Pico-Tesla Magnetic Therapies, LLC. at approximately $91M (range $3.1M–$713M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.27× the median modeled value of Seed Other Health Care companies in 2010–2012 (243 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 16.4 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 2.1× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 92% of Other Health Care peers (5377 compared).
Modeled value ranks above 77% of those peers.
Closest niche peers: Coolsystems Inc, Device Innovation Group, LLC, Envoy Partners Llc, Kare Partners LLC, CuMed LLC.
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.
Recurring-offering pattern: stage-based valuation has lower applicability.